Abstract: The invention relates to a method for identifying the source of shed bioparticles and an apparatus that implements the method. The method involves collecting a sample of bioparticles from the environment, selecting from that sample the bioparticles most effective in identifying their source, and gathering data from those bioparticles to form bioparticle signatures. The bioparticle signatures are then processed into a multi-dimensional vector which is then compared to the multi-dimensional vector derived from a standard using a pattern recognition strategy that identifies the source. The apparatus has a particle collection device to collect the sample, a transfer device that selects information-rich bioparticles and a detector that restricts the movement of the information-rich bioparticles. The restricted movement is then translated into a bioparticle signature.
Type:
Grant
Filed:
July 7, 2008
Date of Patent:
September 2, 2014
Inventors:
Mark A. Hayes, Thomas J. Taylor, Karl Booksh, Neal Woodbury, Pierre Herckes
Abstract: The invention relates to the use of nanopatterned surfaces. It also relates to a method for enriching or isolating cellular subpopulations. To create a simple, versatile and specific method for enriching or isolating cellular subpopulations from a complex mixture, the invention proposes the use of nanopatterned surfaces for isolating and enriching cellular subpopulations from a complex mixture.
Type:
Grant
Filed:
November 7, 2008
Date of Patent:
August 5, 2014
Assignee:
Leibniz-Institut fuer Neue Materialien Gemeinneutzige Gesellschaft mit beschraenkter Haftung
Abstract: A method of alleviating pain associated with tissue damage includes applying salmon thrombin at a tissue damage site, as a single substance in liquid form, or as a powder, a foam, and/or a gel that includes salmon thrombin. A pain relief substance includes a salmon thrombin preparation.
Type:
Grant
Filed:
August 12, 2011
Date of Patent:
July 8, 2014
Assignee:
Sea Run Holdings, Inc.
Inventors:
Evelyn S. Sawyer, Paul A. Janmey, Beth A. Winkelstein
Abstract: The invention relates to a promoter selected from a group of nucleic acids consisting of (a) a nucleic acid having the nucleotide sequence of SEQ ID NO:1; (b) a nucleic acid having a nucleotide sequence derived from SEQ ID NO:1, wherein not more than 10 nucleotides have been added, deleted, substituted and/or inverted from the nucleic acid of SEQ ID NO:1; and (c) a nucleic acid sequence having at least 70% identity with the nucleic acid of (a); wherein the promoter has a length of up to and including 27 nucleotides and wherein the promoter according to options (b) and (c) exhibits at least the 70% of the promoter activity of SEQ ID NO:1 as measured by the amount of recombinant protein produced.
Type:
Grant
Filed:
November 27, 2009
Date of Patent:
July 8, 2014
Assignee:
Bavarian Nordic A/S
Inventors:
Robin Steigerwald, Christine Meisinger-Henschel, Eva Felder
Abstract: A childbirth control system is provided to control the labor process of a patient. The patient's physical information of the patient and her fetus is continuously obtained during the labor via a plurality of diagnosis devices connected to a user terminal. The system includes an analysis module, which generates a childbirth progress data by continuously comparing the series of patient's measurement data with a series of reference measurement data. The childbirth progress data is provided on the user terminal to show the current progress of the childbirth as well as suggestions as to alternative childbirth method and medical treatment options. The system also provides the childbirth progress data to the user terminal of remotely located medical service providers, and allows them to remotely assist the childbirth process.
Abstract: Methods and materials are provided for integrating heterologous nucleic acids into the genome of a cell or virus without disrupting expression of genes adjacent to the insertion site.
Abstract: Devices, methods, and systems are described for administration to at least one biological tissue of at least one device including at least one altered microorganism. In an embodiment, the altered microorganism includes at least one nucleic acid construct encoding at least one therapeutic agent.
Type:
Grant
Filed:
May 28, 2010
Date of Patent:
May 27, 2014
Assignee:
The Invention Science Fund I, LLC
Inventors:
Dario G. Amodei, Mahalaxmi Gita Bangera, Xiaoyan Robert Bao, Anna Bershteyn, Brett Bethke, Philip A. Eckhoff, Kevin Michael Esvelt, Kyle B. Gustafson, Edward K. Y. Jung, William Michael Kaminsky, Jordin T. Kare, Lily Yvonne Kim, Eric C. Leuthardt, Erez Lieberman, Ankur Moitra, Christopher Somogyi, Clarence T. Tegreene, Lowell L. Wood, Jr., Jeremiah James Zartman
Abstract: In the method for introducing a noncanonical amino acid residue into a desired position in a protein, the structure of tRNA is so modified as to have improved affinity for aminoacyl-tRNA synthetase or improved specificity to aminoacyl-tRNA synthetase. An unnatural base is contained at any position in tRNA, whereby the efficiency of aminoacylation of the tRNA with a noncanonical amino acid can be improved.
Abstract: The present invention relates to a nucleic acid containing at least one homing endonuclease site (HE) and at least one restriction enzyme site (X) wherein the HE and X sites are selected such that HE and X result in compatible cohesive ends when cut by the homing endonuclease and restriction enzyme, respectively, and the ligation product of HE and X cohesive ends can neither be cleaved by the homing endonuclease nor by the restriction enzyme. Further subject-matter of the present invention relates to a vector comprising the nucleic acid of the present invention, host cells containing the nucleic acid and/or the vector, a kit for cloning and/or expression of multiprotein complexes making use of the vector and the host cells, a method for producing a vector containing multiple expression cassettes, and a method for producing multiprotein complexes.
Abstract: The invention relates to a method for isolating cells from a tissue sample. In preferred embodiments, chondrocytes are isolated from cartilage tissue in a shorter time than hitherto considered possible.
Type:
Grant
Filed:
August 31, 2007
Date of Patent:
April 15, 2014
Assignee:
Cellcotec B.V.
Inventors:
Jeanine Anna Alphonse Hendriks, Adetola Bamidele Adesida
Abstract: Provided is a cell cultivation method in which the cell is cultured using a peptide hydrogel as a scaffold, for carrying out high-dimensional culture of a cell such as porcine hepatocyte, human hepatocyte, porcine pancreatic islet or human pancreatic islet for a long period under conditions where cell survival, cell morphology and cell functions are maintained. Also provided are a cell culture including a cell and a peptide hydrogel obtained by the above-described cultivation method, a bioreactor including the cell culture, and a cell preparation including the cell culture.
Type:
Grant
Filed:
December 23, 2011
Date of Patent:
April 15, 2014
Assignees:
National University Corporation Okayama University, 3-D Matrix, Ltd.
Abstract: The present invention relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer comprising the analysis of the expression of the marker gene hepsin in an urine sample. It further relates on a non-invasive method for diagnosing prostate cancer and/or assessing the risk of a subject acquiring prostate cancer by determining the expression levels of the marker genes hepsin, EZH2, prostein and PCA3.
Abstract: This disclosure relates to fluorescent cell lines and to the use of such cell lines in monitoring cellular activity, such as angiogenesis. This disclosure further relates to the use of such cell lines in a three-dimensional cell culture to monitor angiogenic and metastatic potential of tumor cells and selecting personalized therapeutics for treatment of cancer.
Type:
Grant
Filed:
June 10, 2010
Date of Patent:
March 25, 2014
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Services
Inventors:
Enrique Zudaire, Frank Cuttitta, Changge Fang
Abstract: The invention provides methods to detect molecular recognition events. The invention also provides methods to detect the presence of or identify a target species based on its interaction with one or more probe species. The methods of the invention are based on amplification of the signal due to each molecular recognition event. The amplification is achieved through photopolymerization, with the polymer formed being associated with the molecular recognition event. In one aspect, a fluorescent polymer, a magnetic polymer, a radioactive polymer or an electrically conducting polymer can form the basis of detection and amplification. In another aspect, a polymer gel swollen with a fluorescent solution, a magnetic solution, a radioactive solution or an electrically conducting solution can form the basis of detection and amplification. In another aspect, detectable particles can be included in the polymer formed. In another aspect, sufficient polymer forms to be detectable by visual inspection.
Type:
Grant
Filed:
April 8, 2011
Date of Patent:
February 18, 2014
Assignee:
The Regents of the University of Colorado, A Body Corporate
Inventors:
Christopher N. Bowman, Kathy Rowlen, Hadley Sikes, Ryan Hansen, Heather Jean Avens
Abstract: Provided is a cell cultivation method in which the cell is cultured using a peptide hydrogel as a scaffold, for carrying out high-dimensional culture of a cell such as porcine hepatocyte, human hepatocyte, porcine pancreatic islet or human pancreatic islet for a long period under conditions where cell survival, cell morphology and cell functions are maintained. Also provided are a cell culture including a cell and a peptide hydrogel obtained by the above-described cultivation method, a bioreactor including the cell culture, and a cell preparation including the cell culture.
Type:
Grant
Filed:
September 29, 2006
Date of Patent:
February 11, 2014
Assignees:
National University Corportion Okayama University, 3-D Matrix, Ltd.
Abstract: A multifunctional invasive cardiovascular diagnostic measurement host is disclosed that interfaces a variety of sensor devices, such as guide wire-mounted pressure sensors, flow sensors, temperature sensors, etc, and provides a multi-mode graphical user interface providing a plurality of displays in accordance with the various types of sensors and measurements rendered by the sensors.
Type:
Grant
Filed:
November 1, 2006
Date of Patent:
January 28, 2014
Assignee:
Volcano Corporation
Inventors:
Howard David Alpert, Paul Michael Hoseit
Abstract: The subject matters of invention relate to expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide ensuring its stable expression by the prokaryotic host as well as an use of the expression cassette. The invention enables stable expression of the target polypeptide, in systems where DNA-dependent RNA polymerase recognizes promoter regulating synthesis of target protein as well as selection marker, which is required for survival of the host.
Type:
Grant
Filed:
June 8, 2007
Date of Patent:
January 14, 2014
Assignee:
Instytut Biotechnologii I Antybiotykow
Inventors:
Andrzej Plucienniczak, Malgorzata Kesik, Grazyna Plucienniczak, Diana Mikiewicz-Sygula
Abstract: Methods to determine drug hydrophobicity and to quantify changes in drug hydrophobicity that optimize drug function by means of differential scanning calorimetry of an endothermic phase transition of a base protein-based polymer, specifically of an elastic-contractile model protein, to which is attached the drug to be evaluated for its hydrophobicity in terms of the change in Gibbs free energy for hydrophobic association, ?GHA have been developed. Also described herein is the preparation of nanoparticles comprised of protein-based polymers, specifically of elastic-contractile model proteins, designed for the binding and desired release rate of a specific drug or class of drugs. Further described herein is a means of targeting the drug-laden nanoparticle to a cell by means of decorating the nanoparticle surface with a molecular entity that selectively binds to the diseased cell or disease causing organism, e.g.
Abstract: A process for the preparation of a composition comprising the cis9, trans11 and trans10, cis12 isomers of conjugated linoleic acid (CLA) comprises: providing a mixture comprising cis9, trans11 and trans10, cis12 isomers of conjugated linoleic acid (CLA) in which one of the cis9, trans11 and trans10, cis12 isomers is present in a first weight ratio X of at least 1.3:1 with respect to the other isomer; and subjecting the mixture to crystallization to form a composition comprising the cis9, trans11 and trans10, cis12 isomers in which one of the cis9, trans11 and trans10, cis12 isomers is present at a second weight ratio Y with respect to the other isomer, wherein Y is greater than X.
Type:
Grant
Filed:
April 4, 2007
Date of Patent:
December 24, 2013
Assignee:
Stepan Specialty Products, LLC
Inventors:
Victoria Taran, Krishnadath Bhaggan, Jeroen Monster
Abstract: The invention disclosed herein generally relates to methods and compositions for inhibiting proteasome activity comprising a syrbactin compound have the structure of Formula (I) or (II).
Type:
Grant
Filed:
November 14, 2008
Date of Patent:
December 3, 2013
Assignee:
Pono Corporation
Inventors:
Andre S. Bachmann, Robert Dudler, Michael Groll